Introduction
Monitoring patient-reported outcomes (PROs) including self-reported mental and functional health of individuals with chronic disease states is important for assuring optimal disease management and patient satisfaction (1). The subjective or self-reported state of well being, as it relates to the health condition, also known as "health related quality of life" (QoL), is a core PRO measure in individuals with advanced chronic kidney disease (CKD) including those with ESRD (1). QoL may also serve as a prognostic measure and predictor for such other outcomes as survival (2-5). Chronic illnesses are often associated with poor QoL (6) . Patients undergoing chronic dialysis treatment have a poorer QoL compared with the general population (7) . Improving QoL and other PROs in the dialysis patient population has evolved as a goal for renal replacement therapy (1). Poor mental health, which may also be manifested as depression, is highly prevalent in CKD patients and is an inde-pendent risk factor for higher mortality in dialysis patients (8 -10) . Worse QoL may also be reported by the patient as poor physical health (11) . Indeed the two main QoL domains or dimensions, i.e., mental health and physical health scores, correlate with other PROs and survival (12) (13) (14) (15) . In dialysis patients, QoL scores also correlate with measures of nutritional status, which per se are strong predictors of longevity in this patient population (16, 17) . In particular, biochemical parameters such as serum albumin and body composition measures may be related to QoL (18 -20) .
Major racial and ethnic disparities including in perceived QoL are among important and unresolved issues that may influence outcomes in dialysis patients (21) (22) (23) . Approximately one third of the 400,000 U.S. dialysis patients are African Americans, although they comprise only 14% of the U.S. general population (24, 25) . The treated ESRD rate for African Americans is one of the highest in the world. Nonetheless, African American and Hispanic patients with ESRD have consistently greater survival over the past several decades than non-Hispanic whites, with a death rate of 187 and 180 per 1000 patient-years at risk, respectively, compared with 207 per 1000 patient-years at risk for the entire U.S. dialysis population (24, 25) . The causes of these disparities remain largely unknown. In a recent survey, Streja et al. (26) showed that survival advantages of African American and Hispanic dialysis patients may be related to differences in nutritional and inflammatory status. Better QoL was reported in African-American maintenance hemodialysis (MHD) patients than the non-African American counterparts (27) . The interplay between QoL, nutritional status, race, and clinical outcomes has not been well studied.
The SF36 is a validated self-administered questionnaire to assess QoL in MHD patients (28) both as a stand alone tool and as a component of the Kidney Disease Quality of Life survey instrument (29) . In this study, we used the SF36 to assess the two main QoL dimensions (mental health and physical health) in a group of MHD patients who were then followed for up to 6 years. We hypothesized that, irrespective of race or nutritional status, mental health and physical health are independently associated with subsequent survival in these patients.
Materials and Methods

Patient Population
We studied MHD patients who participated in the Nutritional and Inflammatory Evaluation in Dialysis (NIED) Study (30) . The original patient cohort was derived from a pool of Ͼ3000 MHD outpatients over 5 years in eight DaVita chronic dialysis facilities in the South Bay area of Los Angeles (see the NIED Study website at www.NIED-Study.org for more details and previous publications (31) (32) (33) . Inclusion criteria were outpatients who had been undergoing MHD treatment for at least 8 weeks, were 18 years of age or older, and signed the Institutional Review Board-approved consent form. From October 1, 2001 through September 30, 2007, 893 MHD patients signed the informed consent form and underwent the periodic evaluations of the NIED Study. For this study, data including SF36 were available for 705 MHD patients. A modified version of the Charlson comorbidity index (i.e., without the age and kidney disease components) was used to assess the severity of comorbidities (34, 35) .
SF36 QoL Scoring System
The SF36 questionnaire has two main dimensions (mental health and physical health) and eight scales or components, i.e., physical function, role physical, body pain, vitality, general health, mental health (not to be confused with the dimension under the same designation), role mental, and social function. The first five of these scales comprise physical health, whereas the last five of these scales constitute the mental health dimension. The scales vitality and general health are part of both the mental health and physical health dimensions. Each of the eight scales is rated 1 to 5, which contribute to the scoring of these scales (see Appendix for more details). The SF36 scores of each of the two dimensions are based on mathematical averaging of the scores of five scales (28, 36) .
Anthropometric Measures
Body weight assessment and anthropometric measurements were performed while patients underwent a hemodialysis treatment or within 5 to 20 minutes after termination of the treatment. Biceps skinfold and triceps skinfold thicknesses were measured with a conventional skinfold caliper using standard techniques as described previously (37, 38) .
Near Infra-Red Interactance
To estimate the percentage of body fat and fat-free body mass, near infra-red (NIR) interactance was measured at the same time as the anthropometric measurements (39) . A commercial NIR sensor with a coefficient of variation of 0.5% for total body fat measurement (portable Futrex 6100) was used. NIR measurements were performed by placing, for several seconds on the upper aspect of the arm without a vascular access, a Futrex sensor and entering the required data (date of birth, gender, weight, and height) of each patient (33) .
Laboratory Tests
All routine laboratory measurements were performed by DaVita Laboratories (Deland, FL) using automated methods. Serum high-sensitivity C-reactive protein (CRP) was measured by a turbidometric immunoassay (40, 41) . IL6 and TNF␣ were measured with immunoassay kits (42) (43) (44) . CRP, TNF␣, and IL6 were measured in the General Clinical Research Center Laboratories of Harbor-UCLA Medical Center. Serum prealbumin was measured using immunoprecipitin analysis. Plasma total homocysteine concentrations were determined by HPLC in the Harbor-UCLA Clinical Laboratories.
can-American (n ϭ 223), and 55% were diabetic. The mean dialysis vintage was 30 Ϯ 32 months (median: 19 months; interquartile range: 7 to 44 months). Tables 1 and 2 show the values of relevant demographic and clinical variables according to the quartiles of SF36 mental and physical health dimensions, respectively. The proportions of women and diabetics were lower in the fourth quartile of the SF36 dimensions. In addition to diabetes mellitus, Charlson morbidity scores, triceps skinfolds, and NIR body fat percentages showed decreasing trends across im-proving mental and physical health score quartiles. Among laboratory measures, serum albumin and creatinine levels increased across increasing quartiles of SF36 scores. Table 3 shows the correlation coefficients between mental and physical health scores and relevant variables. The two SF36 dimensions were positively correlated with serum albumin and creatinine concentrations and negatively with total body fat percentage. Figures  1-3 show serum albumin and creatinine concentrations Values expressed as mean Ϯ SD or percent. Albumin in g/dl may be converted to g/L by multiplying by 10; creatinine in mg/dl to mol/L by multiplying by 88.4; calcium in mg/dl to mmol/L by multiplying by 0.2495; phosphorus in mg/dl to mmol/L by multiplying by 0.3229. Ferritin levels expressed in ng/ml and g/L are equivalent. White blood cell count in 103/l and 109/L is equivalent. P for dialysis dose (vintage), ferritin level, vitamin D dose, CRP level, IL6 levels, and TNF level are based on logarithmic values of these measures. nPNA, normalized protein nitrogen appearance; nPCR, normalized protein catabolic rate; TIBC, total iron binding capacity. and the NIR measured total body fat percentage, respectively, across the quartiles of the two dimensions and eight scales of the SF36 in all 705 MHD patients. The two nutritional biomarkers were incrementally higher across higher QoL score quartiles, whereas body fat exhibited an opposite trend. During the follow-up period of up to 6 years, 274 (39%) patients died, 92 (11%) underwent transplantation, and 147 (18%) left the cohort. Table 4 shows the HR of mortality across quartiles of mental and physical health.
The death HR increased across worsening QoL scores even after extensive multivariate adjustment for demographics and measures of nutrition and inflammation including several inflammatory markers and cytokines. Figure 4 shows the cubic splines of the mortality predictabilities of mental and physical health scores. A linear trend toward increased death risk with worse mental health score was observed in the entire cohort. Figures 5 and 6 show the cubic splines in African-American and other MHD patients separately. The Cox regression estimated HRs of death for the aforementioned linear mortality predictabilities of the two dimensions and eight scales are listed in Table 5 for the entire cohort and by race. In the fully adjusted models, for each 10-unit drop in the mental and physical health scores, the death HRs (and 95% confidence intervals) were 1.12 (1.05 to 1.19) and 1.08 (1.02 to 1.15), respectively (P Ͻ 0.001).
Mental health scores remained robust predictors of survival in both African-American and other races, whereas physical health and the eight scales did not show statistically significant associations with death. In 223 African-American MHD patients, each 10-unit drop in the mental health score was associated with a 10% increase in death risk, i.e., a death HR of 1.10 (1.03 to 1.18; P Ͻ 0.001). The spline analyses in Figure 5 confirmed the substantially more linear and incremental associations of mental health score with mortality in African Americans. An increasing trend of mortality was associated with lower scores on mental and physical health dimensions of SF36, and it was robust even after controlling for case-mix and other nutritional and inflammatory measures. There was a 62 and 45% higher chance of death in patients with the lowest (versus highest) score quartile of mental and physical health of SF36, respectively. Each 10-unit decrease in each of the two dimensions and eight subscales of the SF36 score was associated with 8 to 15% higher mortality. However, African-American race did not exhibit a statistically significant interaction with QoL-mortality association (P for interaction terms Ͼ 0.20).
Discussion
In this prospective 6-year cohort study of 705 MHD patients including 223 African Americans, lower QoL scores derived from self-administered SF36 questionnaires were associated with higher mortality risk. Both the mental health and physical health dimensions of the SF36 showed significant associations with mortality in all MHD patients. The death predictability of the mental health scores was slightly more pronounced in African American, whereas the association of worse physical health score and death risk did not reach statistical significance in this group. Lower QoL scores not only correlated with surrogates of protein energy wasting, including lower serum albumin and creatinine levels, but also with obesity, i.e., higher total body fat percentage. These findings may have important implications for the management of dialysis patients who frequently have poor health-related QoL and nutritional derangements including both protein energy wasting and obesity.
Monitoring PROs including the subjective state of well being, together known as QoL measurements, is of particular importance for CKD patients, because the physical and mental debilities experienced by CKD patients can be insidious and yet have grave consequences (1, 6, 9) . In recent years, more attention has been drawn toward reexamining the overall role and potential application of patient self-reported states of well being and functioning by using self-administered QoL questionnaires in dialysis populations (9 -12) . The SF36 is one of the most commonly used PRO instruments for QoL evaluation in maintenance dialysis patients (9, 10) . Our study suggests that better QoL was associated with higher predialysis serum creatinine and albumin levels, which are surrogates, respectively, for larger muscle mass and/or greater meat intake, and for higher visceral protein stores. Lowrie et al. (46) found that the SF36 score was significantly correlated with serum albumin, creatinine, and hemoglobin. Ohri-Vachaspati and Sehgal (47) showed that inadequate protein nutrition, as reflected by low serum albumin level and low protein nitrogen appearance, was independently associated with poor QoL. The mental and physical health dimensions showed an especially strong association with the patients' protein/energy status. These nutritional markers showed a significantly positive correlation with both dimensions in both unadjusted and adjusted models. These finding are also consistent with previous reports by Lowrie et al. (48) , Kalanar-Zadeh et al.
(2), and Ohri-Vachaspati and Sehgal (47) .
In this study, we did not find any association of QoL with inflammatory markers. Patients who were old or diabetic or who had higher comorbidity or higher body fat reported lower mental and physical health scores. SF36 had a significant negative correlation with the percentage of body fat, as measured by NIR technology, indicating that obese MHD outpatients tended to perceive a worse QoL. Triceps skinfold measurement, another surrogate of body fat, was also negatively correlated with the scores. Our study suggests that worse QoL was associated with obesity. Although obesity is associated with deleterious outcomes in the general population, in MHD patients, the association between body mass index and mortality appears in the opposite direction, a phenomenon known as "obesity paradox" or "reverse epidemiology" (33,49 -51) . Although this may be regarded as a contradiction to the assumed association between a poor nutritional state and lower SF36 score, being overweight is not the same as being well nourished. Goller et al. (52) observed that overweight dialysis patients had lower SF36 scores and were more impaired in physical functioning. If the association between obesity and poorer QoL in ESRD patients can be further verified, the SF36 may be one of the few reliable tools to detect higher-risk patients with poor clinical outcomes among those patients who are usually considered as being "not-malnourished" by nutritional assessment.
Similar to our results, previous studies found that the self-reported QoL score was independently predictive of mortality in the elderly individuals. DeOreo (4) recently reported that a SF36-associated physical health dimension score below the median value in MHD patients was twice as likely to be associated with mortality and 1.5 times as likely with hospitalization. Lowrie et al. (5) found a similar association between both physical and mental health dimensions of the SF36 and dialysis mortality In this study, (56) . Whereas overall long-term survival in MHD patients is dreadfully low (23, 57) , there exists a racial survival paradox, in that African American dialysis patients have a greater survival than whites (58) This is despite the evidence that minority MHD patients are more likely to have such poor survival indicators as hypoalbuminemia and anemia or limited pre-ESRD care (58) . Similarly, for the healthier MHD patients on transplant wait lists, the annual mortality rate is higher for non-Hispanics compared with African Americans (59 -61) . We also evaluated racial effects in our study and found that mental health score had a robust and linear association with mortality, but physical health score did not in AAs. Our findings suggest that mental health is a stronger outcome predictor in AA MHD patients. Our findings of poor mental health score and poor clinical outcomes in AA MHD patients are consistent with a report of Fischer et al. (62) , who found, among a cohort of 628 AAs with stages 3 to 5 CKD, a high prevalence of increased depressive affect that was infrequently treated with anti-depressants and that was associated with poorer quality of life.
A potential limitation of this study is a selection bias during enrollment. However, because mortality in our cohort was less than the base MHD population (30) , it might be argued that a selection bias with such a direction would lead to a bias toward the null, so without this bias, our results may have been even stronger. Moreover, our cohort was younger and have shorter dialysis vintage than the national U.S. dialysis population. Other limitations include lack of information on dialysis access, dialysis membrane, depression treatment, and other known or unknown confounders. The strengths of our study include the sample size, which was moderately large, the comprehensive clinical and laboratory evaluations with concomitant assessment of QoL and body composition measures, and detailed evaluation of comorbid states by study physicians. Unlike previous cohorts that have been studied, ours has been extensively characterized for markers of inflammation and nutritional status, including direct total body fat measurements. The availability of these measures allowed us to assess the interaction of nutritional and inflammatory markers in this group of MHD patients. Another strength is that the subjects were selected randomly without prior knowledge of their status. Finally, the very same blood specimens that were used to measure markers of protein energy wasting were also used for the cytokines measurements.
In conclusion, in MHD patients, a low mental and physical health score on the self-administered SF36 QoL questionnaire was independently associated with poor survival. The mental health score per se was the more powerful predictor of mortality in this patient population, in whom each 10-unit lower score was associated with an approximately 12% higher death risk. A low mental health score was even more predictive of mortality among African Americans compared to whites, whereas low physical health was not. Low QoL not only correlated with low serum albumin and creatinine levels, two biochemical markers of protein energy wasting and predictors of poor survival, but also with higher total body fat percentage, which is both an obesity measure and a surrogate of more nutritional reserves and aligned with greater survival in MHD patients. These findings suggest that, despite the reported survival advantages of body fat, known as the obesity paradox, MHD patients with higher total body fat perceive a lower QoL. Hence, the survival advantages of obesity in MHD patients appears in the opposite direction to obesity-QoL relationship. Given the robust and linear association of the perceived mental health status with longevity in MHD patients, including among African Americans, clinical trials to examine the effectiveness of methods to improve QoL are warranted. Nutritional and anti-inflammatory interventions that can improve protein energy wasting and QoL without increasing body fat might be particularly indicated.
